NCT03693807 A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT03690921 Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial Status COMPLETED Phase PHASE2
NCT03668418 Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos Status UNKNOWN Phase N/A
NCT03617913 Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer Status COMPLETED Phase PHASE2
NCT03579004 Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer Status UNKNOWN Phase PHASE2
NCT03533582 Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03532711 Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer Status COMPLETED Phase N/A
NCT03522649 A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT03505320 A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03504397 A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03414983 An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread Status COMPLETED Phase PHASE2/PHASE3
NCT03387111 QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed Status TERMINATED Phase PHASE1/PHASE2
NCT03387098 QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy Status TERMINATED Phase PHASE1/PHASE2
NCT03386838 An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck Status WITHDRAWN Phase PHASE3
NCT03349177 Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy Status UNKNOWN Phase PHASE2/PHASE3
NCT03340896 Trial of Laryngeal Preservation Comparing Induced CT Followed by RT vs CT Concomitant to RT Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03337087 Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03336216 A Study of Cabiralizumab Given With Nivolumab With and Without Chemotherapy in Patients With Advanced Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT03329248 QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy Status TERMINATED Phase PHASE1/PHASE2